Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...

Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...

In this video, Lukas Delasos, DO, discusses the accelerated approval of zongertinib as an initial treatment option for adults ...

Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially ...

A team from UNIGE has designed a molecular system that distinguishes and neutralizes cancer cells with unprecedented ...

How can cancer cells be targeted without damaging healthy tissue? This is one of the major challenges facing oncology today.

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...

Using a variety of laboratory and animal models, the team found that cysteine fuels the production of the antioxidant ...

Researcher at Harvard Medical School develops AI-driven molecule targeting tumor mitochondria defects to destroy cancer ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Cystic adenocarcinoma (marked in red) of the pancreas (outlined in green). Contrast‑enhanced ...

Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune defenders and biding their time until conditions are ripe for establishing a ...